C
IOVA icon

Covestor’s Iovance Biotherapeutics IOVA Stock Holding History

Covestor’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
183
+129
+239% +$490 ﹤0.01% 2199
2026
Q1 		$0 Buy
54
+30
+125% +$96 ﹤0.01% 2513
2025
Q4 		$0 Hold
24
– – ﹤0.01% 2486
2025
Q3 		$0 Hold
24
– – ﹤0.01% 2504
2025
Q2 		$0 Sell
24
-2
-8% -$5 ﹤0.01% 2457
2025
Q1 		$0 Buy
26
+10
+63% +$52 ﹤0.01% 2462
2024
Q4 		$0 Buy
16
+1
+7% +$9 ﹤0.01% 2472
2024
Q3 		$0 Sell
15
-1
-6% -$9 ﹤0.01% 2453
2024
Q2 		$0 Buy
16
+6
+60% +$64 ﹤0.01% 2473
2024
Q1 		$0 Sell
10
-10
-50% -$116 ﹤0.01% 2472
2023
Q4 		$0 Sell
20
-3
-13% -$16 ﹤0.01% 2394
2023
Q3 		$0 Sell
23
-3
-12% -$20 ﹤0.01% 2383
2023
Q2 		$0 Buy
26
+11
+73% +$79 ﹤0.01% 2375
2023
Q1 		$0 Hold
15
– – ﹤0.01% 2287
2022
Q4 		$0 Sell
15
-1
-6% -$8 ﹤0.01% 2310
2022
Q3 		$0 Sell
16
-7
-30% -$81 ﹤0.01% 2273
2022
Q2 		$0 Sell
23
-14
-38% -$183 ﹤0.01% 2122
2022
Q1 		$1K Buy
37
+3
+9% +$46 ﹤0.01% 1852
2021
Q4 		$1K Buy
+34
New +$749 ﹤0.01% 1791

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Covestor's IOVA Position: Q2 2026 in Review

Covestor increased its Iovance Biotherapeutics (IOVA) stake by 239% in Q2 2026, buying an estimated $490 and bringing the position to 183 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Covestor first reported a position in IOVA in Q4 2021 and has held it in 19 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Covestor held 183 shares of Iovance Biotherapeutics worth $1K as of Q2 2026.
  • Covestor bought 129 Iovance Biotherapeutics shares in Q2 2026, an estimated $490.
  • Iovance Biotherapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2199 holding.
  • Covestor first reported a position in Iovance Biotherapeutics in Q4 2021 and has held it in 19 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.